PCI Biotech: Presentation of fimaCHEM for bile duct cancer at IPA masterclass series Guest UserNovember 8, 2021
PCI Biotech: US patent for the vaccine technology (fimaVACC) in combination with checkpoint inhibitors Guest UserMay 31, 2021
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer Guest UserMay 28, 2021
OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies Guest UserMay 5, 2021
PCI Biotech: First US patient enrolled in the fimaCHEM pivotal RELEASE study Guest UserApril 30, 2021
